Robert M. Vanhimbergen net worth and biography

Robert Vanhimbergen Biography and Net Worth

Robert (Bob) VanHimbergen serves as Executive Vice President and Chief Financial Officer at Elanco Animal Health, overseeing financial operations including treasury, investor relations, tax functions, information technology, and transformation.

Bob brings extensive experience in large multinational corporations. He joins Elanco from Hillenbrand, where he has served as Senior Vice President and Chief Financial Officer since April 2022. His career includes a significant tenure at Johnson Controls International plc, where he has served as Vice President, Corporate Controller since December 2017. With over 15 years at Johnson Controls, he held various roles of increasing responsibility, including Chief Financial Officer of Yanfeng Automotive Interiors in Shanghai, China. Before Johnson Controls, Bob spent nearly a decade with PricewaterhouseCoopers LLP, working with large multinational manufacturing companies.

Bob also actively engages in non-profit organizations, maintaining deep connections to Midwestern values. He holds the position of Chairman for the Ascension Southeast Wisconsin Board and the Ascension Wisconsin Foundation. Additionally, he led the 2023 campaign for the American Heart Association in Milwaukee, WI, and has previously served on the boards of several nonprofit organizations in Milwaukee. He was recognized as one of the 2021 Milwaukee Philanthropic 5 award winners.

What is Robert M. Vanhimbergen's net worth?: The estimated net worth of Robert M. Vanhimbergen is at least $2.96 million as of December 11th, 2025. Vanhimbergen owns 124,233 shares of Elanco Animal Health stock worth more than $2,962,709 as of January 12th. This net worth approximation does not reflect any other investments that Vanhimbergen may own. Learn More about Robert M. Vanhimbergen's net worth.
How do I contact Robert M. Vanhimbergen?: The corporate mailing address for Vanhimbergen and other Elanco Animal Health executives is 2500 INNOVATION WAY, GREENFIELD IN, 46140. Elanco Animal Health can also be reached via phone at (877) 352-6261 and via email at [email protected]. Learn More on Robert M. Vanhimbergen's contact information.
Has Robert M. Vanhimbergen been buying or selling shares of Elanco Animal Health?: Robert M. Vanhimbergen has not been actively trading shares of Elanco Animal Health during the past quarter. Most recently, on Thursday, December 11th, Robert M. Vanhimbergen bought 6,950 shares of Elanco Animal Health stock. The stock was acquired at an average cost of $21.64 per share, with a total value of $150,398.00. Following the completion of the transaction, the chief financial officer now directly owns 124,233 shares of the company's stock, valued at $2,688,402.12. Learn More on Robert M. Vanhimbergen's trading history.
Who are Elanco Animal Health's active insiders?: Elanco Animal Health's insider roster includes John Bilbrey (Director), Art Garcia (Director), Michael Harrington (Director), R. Hoover (Director), Lawrence Kurzius (Director), Rajeev Modi (Insider), Jeffrey Simmons (President & CEO), Robert Vanhimbergen (CFO), and Todd Young (Insider). Learn More on Elanco Animal Health's active insiders.
Are insiders buying or selling shares of Elanco Animal Health?: During the last year, Elanco Animal Health insiders bought shares 6 times. They purchased a total of 63,450 shares worth more than $1,148,883.00. The most recent insider tranaction occured on December, 12th when Director Lawrence Erik Kurzius bought 10,000 shares worth more than $213,000.00. Insiders at Elanco Animal Health own 0.9% of the company. Learn More about insider trades at Elanco Animal Health.
Information on this page was last updated on 12/12/2025.

Robert M. Vanhimbergen Insider Trading History at Elanco Animal Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/11/2025	Buy	6,950	$21.64	$150,398.00	124,233

Robert M. Vanhimbergen Buying and Selling Activity at Elanco Animal Health

Elanco Animal Health Company Overview

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Today's Range

Now: $23.85

$23.28

$23.90

50 Day Range

MA: $22.27

$20.45

$23.74

2 Week Range

Now: $23.85

$8.02

$23.90

Volume

4,648,957 shs

Average Volume

4,356,914 shs

Market Capitalization

$11.85 billion

P/E Ratio

397.53

Dividend Yield

N/A

Beta

1.87